Jan Hillson
Directeur/Bestuurslid bij ELEDON PHARMACEUTICALS, INC.
Vermogen: - $ op 30-04-2024
Profiel
Jan L.
Hillson is currently an Independent Director at Eledon Pharmaceuticals, Inc. and a Senior Vice President-Clinical Development at Provention Bio, Inc. Previously, Dr. Hillson held positions as a Medical Director at Xcyte Therapies, Inc., Senior Director at ZymoGenetics, Inc., Vice President-Clinical & Translational Research at Momenta Pharmaceuticals, Inc., Senior Vice President-Drug Development at ChemoCentryx, Inc., Assistant Professor at the University of Washington, Division Head at Virginia Mason Medical Center, and Senior Vice President-Clinical Development at Alpine Immune Sciences, Inc. Dr. Hillson received an undergraduate degree from Michigan State University, a graduate degree from the California Institute of Technology, a graduate degree from the Scripps Institution of Oceanography, and a graduate degree from Stanford University School of Medicine.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 31-03-2023 | 0 ( -.--% ) | - $ | 30-04-2024 |
Actieve functies van Jan Hillson
| Bedrijven | Functie | Begin |
|---|---|---|
| ELEDON PHARMACEUTICALS, INC. | Directeur/Bestuurslid | 02-07-2021 |
| PROVENTION BIO, INC. | Corporate Officer/Principal | 01-11-2021 |
Eerdere bekende functies van Jan Hillson
| Bedrijven | Functie | Einde |
|---|---|---|
| MOMENTA PHARMACEUTICALS, INC. | Hoofd Techniek/Wetenschap/O&O | 01-01-2016 |
ZymoGenetics, Inc.
 ZymoGenetics, Inc. Pharmaceuticals: MajorHealth Technology ZymoGenetics, Inc. develops protein based drugs. It focuses on the discovery, development, manufacture, and commercialization of therapeutic proteins for the treatment of human diseases, including homeostasis, inflammatory and autoimmune diseases, cancer, and viral infections. The company was founded by Earl W. Davie, Benjamin D. Hall and Michael Smith in 1981 and is headquartered in Seattle, WA. | Corporate Officer/Principal | 01-01-2013 |
Virginia Mason Medical Center
 Virginia Mason Medical Center Medical/Nursing ServicesHealth Services Virginia Mason Medical Center provides healthcare services. It offers primary and cancer care, diabetes center, digestive disorders, heart care, neurology and neurosurgery, medicine, surgery, urology, and orthopedics and sports. The company was founded by James Tate Mason, John M. Blackford, and Maurice Dwyer in 1920 and is headquartered in Seattle, WA. | Corporate Officer/Principal | - |
| ALPINE IMMUNE SCIENCES, INC. | Hoofd Techniek/Wetenschap/O&O | - |
University of Washington
 University of Washington Other Consumer ServicesConsumer Services University of Washington functions as a College/University. The company is headquartered in Seattle, WA. | Corporate Officer/Principal | - |
Opleiding van Jan Hillson
| Stanford University School of Medicine | Graduate Degree |
| California Institute of Technology | Graduate Degree |
| Michigan State University | Undergraduate Degree |
| Scripps Institution of Oceanography | Graduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 2 |
|---|---|
| ALPINE IMMUNE SCIENCES, INC. | Health Technology |
| ELEDON PHARMACEUTICALS, INC. | Health Technology |
| Bedrijven in privébezit | 6 |
|---|---|
ChemoCentryx, Inc.
 ChemoCentryx, Inc. Pharmaceuticals: MajorHealth Technology ChemoCentryx, Inc. is a biopharmaceutical company, which engages in the development and commercialization of medicines. It focuses on inflammatory disorders, autoimmune diseases, and cancer. Its drug candidates such as Avacopan and CCX140, selectively blocks a specific chemoattractant receptor, leaving the rest of the immune system intact. The company was founded by Thomas J. Schall in 1997 and is headquartered in San Carlos, CA. | Health Technology |
Momenta Pharmaceuticals, Inc.
 Momenta Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Momenta Pharmaceuticals, Inc. operates as a biotechnology company that focuses on the discovery and development of novel biologic therapies for the treatment of rare immune-mediated diseases. Its products include the Glatiramer acetate injection and Enoxaparin Sodium injection. The company was founded by Ram Sasisekharan, Paul R. Schimmel, and Ganesh Venkatraman Kaundinya in May 2001 and is headquartered in Cambridge, MA. | Health Technology |
ZymoGenetics, Inc.
ZymoGenetics, Inc. Pharmaceuticals: MajorHealth Technology ZymoGenetics, Inc. develops protein based drugs. It focuses on the discovery, development, manufacture, and commercialization of therapeutic proteins for the treatment of human diseases, including homeostasis, inflammatory and autoimmune diseases, cancer, and viral infections. The company was founded by Earl W. Davie, Benjamin D. Hall and Michael Smith in 1981 and is headquartered in Seattle, WA. | Health Technology |
| Xcyte Therapies, Inc. | Health Technology |
Virginia Mason Medical Center
Virginia Mason Medical Center Medical/Nursing ServicesHealth Services Virginia Mason Medical Center provides healthcare services. It offers primary and cancer care, diabetes center, digestive disorders, heart care, neurology and neurosurgery, medicine, surgery, urology, and orthopedics and sports. The company was founded by James Tate Mason, John M. Blackford, and Maurice Dwyer in 1920 and is headquartered in Seattle, WA. | Health Services |
Provention Bio, Inc.
 Provention Bio, Inc. Pharmaceuticals: MajorHealth Technology Provention Bio, Inc. is a clinical-stage biopharmaceutical company, which engages in the development and commercialization of novel therapeutics and solutions. Its products include PRV-031 for the interception of type 1 diabetes (T1D), PRV-015 for the treatment of gluten-free diet non-responding celiac disease, PRV-6527 for Crohn’s disease, PRV-3279 for the treatment of lupus, and PRV-101 for the prevention of acute coxsackie virus B (CVB), and the prevention of type 1 diabetes (T1D) onset. The company was founded by Francisco Leon and Ashleigh Palmer on October 4, 2016 and is headquartered in Red Bank, NJ. | Health Technology |
